A Phase 1 Study of Evaluate the Safety, Tolerability and Efficacy of MK-8353 (formerly SCH 900353) in Subjects with Advanced Solid Tumors (Protocol No.001) formerly P06203
Description: 

The purpose of this study is to find the highest dose of SCH 900353 that can be given without causing severe side effects. In the second part of the study, the purpose will be to find out what effects (good and bad) SCH 900353 has on you and your type of colorectal cancer or melanoma.

Study Number: 

I 182110

Phase: 
I
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01358331

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.